COMP <GO>
ATRO vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Astronics Corporation (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ATRO 4
— TMO 7
■ METRIC PARITY
LAST: $59.39 (-5.55%) • MKT CAP: $2.70B
options-implied-move
—
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ATRO VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ATRO | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.20% | 9.30% | +3.90 | ATRO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 39.5x | 30.4x | +9.10 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 2.77% | 2.40% | +0.37 | ATRO | /fcf-yield <GO> |
| Operating Margin | 8.90% | 17.40% | -8.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 15.10% | -11.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 8.40% | 3.90% | +4.50 | ATRO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.37 | 4.50 | +0.87 | ATRO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.4 | 62.9 | -14.50 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 85.7x | 36.3x | +49.40 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.70B | $262.22B | -$259.51B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ATRO REV | TMO REV | ATRO GROSS % | TMO GROSS % | ATRO FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $862.1M | $44.56B | 29.9% | — | $74.8M | $6.29B |
| FY 2024 | $795.4M | $42.88B | 27.7% | — | $30.6M | $7.27B |
| FY 2023 | $689.2M | $42.86B | — | — | -$23.9M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ATRO // BETA —
TMO // BETA 0.94